Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced-stage serous ovarian or primary peritoneal cancer: A Gynecologic Oncology Group (GOG) study

T.C Krivak,D Tritchler,K.N Moore,K Kaufman,H Lankes,D.K Armstrong,M.J Birrer,M.F Brady,M.A Bookman

doi:10.1016/j.ygyno.2014.03.066

Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced-stage serous ovarian or primary peritoneal cancer: A Gynecologic Oncology Group (GOG) study

T.C Krivak, D Tritchler + Show 7 more

https://doi.org/10.1016/j.ygyno.2014.03.066

Copy DOI

Journal: Gynecologic Oncology

Publication Date: Jun 1, 2014

Affiliation: Gynecologic Oncology Group, University of Oklahoma, Oklahoma City University, Johns Hopkins Medicine, Sidney Kimmel Cancer Center, Johns Hopkins University, Massachusetts General Hospital, University at Buffalo, State University of New York, University of Arizona

#Advanced Stage Epithelial Ovarian Cancer #Primary Peritoneal Cancer + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Objectives: Identification of novel pathways involved in advanced stage epithelial ovarian cancer (EOC) is essential to improve patient outcomes. This study proposes to evaluate single nucleotide polymorphisms (SNPs) associated with progression-free survival (PFS) and overall survival (OS) in patients with advanced-stage serous EOC and primary peritoneal cancer (PPC).

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Gynecologic Oncology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.